Cannabinoids in experimental stroke: a systematic review and meta-analysis
Cannabinoids (CBs) show promise as neuroprotectants with some agents already licensed in humans for other conditions. We systematically reviewed CBs in preclinical stroke to guide further experimental protocols. We selected controlled studies assessing acute administration of CBs for experimental st...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Published: |
SAGE
2015
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/38438/ |